Gallbladder Cancer
119
13
18
60
Key Insights
Highlights
Success Rate
81% trial completion
Published Results
17 trials with published results (14%)
Research Maturity
60 completed trials (50% of total)
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
11.8%
14 terminated out of 119 trials
81.1%
-5.5% vs benchmark
7%
8 trials in Phase 3/4
28%
17 of 60 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 60 completed trials
Clinical Trials (119)
Integrated Cancer Repository for Cancer Research
Safety and Efficacy of CD160-Enhanced Autologous Antigen-Specific T-Cells (BTC-Ag-T) in Advanced Biliary Tract Cancer
A Study of LSTA1 When Added to Standard of Care Versus Standard of Care Alone in Patients With Advanced Solid Tumors
Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes
Trifluridine/Tipiracil + Oxaliplatin in Participants With Advanced or Metastatic Biliary Tract Cancer
EULAT Eradicate GBC
The PLATON Network
Copper Cu 64 Anti-CEA Monoclonal Antibody M5A PET in Diagnosing Patients With CEA Positive Cancer
STALL vs Sole Local Wound Infiltration in Laparoscopic Cholecystectomy
Biomarker Discovery in Patients With Advanced Biliary Tract Cancer
Artificial Intelligence-based Tumor Microenvironment Analysis for Prognosis Prediction in Gallbladder Cancer
Feasibility Study of Multi-Platform Profiling of Resected Biliary Tract Cancer
To Evaluate Efficacy and Safety of TT-00420 (Tinengotinib) as Monotherapy and Combination Therapy in Patients With Advanced Solid Tumors
Predicting Incidental Gallbladder Cancer
Gem+Nab-P+LEN+TIS for Advanced Unresectable BTC (GALENT-BT)
Study of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid Tumors
PLATON - Platform for Analyzing Targetable Tumor Mutations (Pilot-study)
Global Evaluation of Cholecystectomy Knowledge and Outcomes
Neoadjuvant Gemcitabine Plus Cisplatin With or Without Durvalumab in Resectable Biliary Tract Cancer
Proteomic Analysis of Patients Undergoing Bariatric Surgery